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Abstract
Exendin-4 is a molecule currently used, in its synthetic form exenatide, for the treatment of type 2 diabetes mellitus.
Exendin-4 binds and activates the Glucagon-Like Peptide-1 Receptor (GLP-1R), thus inducing insulin release. More recently,
additional biological properties have been associated to molecules that belong to the GLP-1 family. For instance, Peptide YY
and Vasoactive Intestinal Peptide have been found to affect cell adhesion and migration and our previous data have shown
a considerable actin cytoskeleton rearrangement after exendin-4 treatment. However, no data are currently available on the
effects of exendin-4 on tumor cell motility. The aim of this study was to investigate the effects of this molecule on cell
adhesion, differentiation and migration in two neuroblastoma cell lines, SH-SY5Y and SK-N-AS. We first demonstrated, by
Extra Cellular Matrix cell adhesion arrays, that exendin-4 increased cell adhesion, in particular on a vitronectin substrate.
Subsequently, we found that this molecule induced a more differentiated phenotype, as assessed by i) the evaluation of
neurite-like protrusions in 3D cell cultures, ii) the analysis of the expression of neuronal markers and iii) electrophysiological
studies. Furthermore, we demonstrated that exendin-4 reduced cell migration and counteracted anchorage-independent
growth in neuroblastoma cells. Overall, these data indicate for the first time that exendin-4 may have anti-tumoral
properties.
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Introduction
Glucagon-Like Peptide-1 (GLP-1) is mainly produced by
enteroendocrine L-cells in response to nutrient ingestion and its
principal effect is related to the induction of insulin secretion.
Exendin-4 is a more stable GLP-1 analogue [1] currently used for
the treatment of Type2 diabetes mellitus in its synthetic form
exenatide. GLP-1 receptors (GLP-1R), mainly expressed in the
pancreas, are also located in various organs and tissues including
the central nervous system [2], where they regulate homeostatic
functions, such as feeding behaviour, gastric motility, gluco-
regulation and cardiovascular function [3]. GLP-1R knock-out
mice present reduced learning abilities and are more susceptible to
neuronal degeneration in the hippocampus than wild type mice
[4] and in vitro neuroprotective effects of GLP-1 analogues have
been thoroughly investigated [5], [6]. To date, little has been
reported on the effects of GLP-1 and exendin-4 on tumor cells.
GLP-1R expression is detectable in human tumors including
endocrine tumors, tumors of the nervous system and embryonic
tumors [7]. Recently, an inhibitory effect of exendin-4 on cell
growth in colon CT26 [8] and in breast [9] cancer cells has been
reported. The effect of molecules with neuroprotective and
differentiating properties on tumor cell invasive potential has
been investigated [10]. Moreover, the influence of gastrointestinal
peptides belonging to the family of GLP-1 (e.g. Peptide YY and
Vasoactive Intestinal Peptide) on cell adhesion and migration has
been assessed in small intestinal cells [11] and in human T
lymphocytes [12]. However, no data on the effects of exendin-4 on
tumor cell motility are currently available. Studies addressing the
pro-metastatic effect of Dipeptydil-Peptidase IV, the enzyme
committed to the inactivation of GLP-1, on different types of
cancer cells [13], [14], [15] suggest a possible role of exendin-4 on
tumor cell motility. Neuroblastoma (NB) is the second most
common solid tumor in children, metastatic in 70% of patients at
diagnosis. NB arises from the developing sympathetic nervous
system and its etiology is not clearly understood; metastatic spread
of NB can happen by both lymphatic and hematogenous routes
[16]. We have previously demonstrated differentiating actions of
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exendin-4 in NB SH-SY5Y cells, as assessed by the increasing
number of neurites, changes in intracellular actin and tubulin
distribution and increase of both Na+ channel conductance and
Ca2+ currents (T- and L-type) amplitude, typical of a more mature
neuronal phenotype [17]. In this study we investigate the effects of
exendin-4 on cell adhesion, differentiation and migration, which in
turn affects tumor spread and metastatization, in two NB cell lines
and in human neuronal precursors, as a non-tumoral counterpart.
Materials and Methods
Cells and Treatments
The human NB cell lines SH-SY5Y and SK-N-AS (American
Type Culture Collection, Manassas, VA, USA) were cultured in
RPMI medium with 10% FBS, 2 mM L-glutamine, 100 IU/ml
penicillin, 100 mg/ml streptomycin and maintained at 37uC in a
humidified atmosphere (5% CO2/95% air). Fetal neuroepithelial
cell cultures (FNC) were isolated from human fetal olfactory
neuroepithelium by Vannelli et al. [18]. Reagents for cell cultures
were from Sigma Chemical Co. (St. Louis, MO, USA). The cells
were seeded in six-well plates, maintained in low serum conditions
(RPMI medium with 2% FBS), and treated with exendin-4
(0.3 mM) (Sigma) for 24 and 48 h. The morphological evaluation
of the differentiation of FNC and SK-N-AS cells was performed as
previously reported [17]. Human mesenchymal stromal cells
(hMSC) were isolated in collaboration with Dr. Riccardo Saccardi
(Haematology Unit, Careggi Hospital, Florence, Italy), as
described previously [19] and maintained for 24 hours in serum-
free medium to obtain conditioned medium for migration assays in
which we detected the release of stromal derived factor-1 (SDF1)
by Quantikine ELISA Human CXCL12/SDF-1a Immunoassay
(R&D systems). Cell proliferation was evaluated by cell counting
and DNA synthesis [20], [21] and cell viability by MTS assay [17].
Figure 1. Expression of GLP1R and cell proliferation assays. RT-PCR analysis of the expression of the GLP1R in all the neuronal cell lines and in
pancreas taken as the positive control. Amplicon length= 240 basepairs M 100 bp=Molecular weight marker 100 basepairs (A). Cell proliferation
assay performed in SK-N-AS and SH-SY5Ycells after treatment with 0.3 mM exendin-4 (in 2% FBS) for 24 h. Cpm=counts per minute; C 2%= control
cells in 2% FBS, EXE = exendin-4. +EXE vs. C 2%, p.0.05). C 10%= control cells in 10% FBS (standard medium, used as the positive control) (B).
doi:10.1371/journal.pone.0071716.g001
Effects of Exendin-4 in Neuroblastoma Cells
PLOS ONE | www.plosone.org 2 August 2013 | Volume 8 | Issue 8 | e71716
Bengal Rose Adhesion Assay and ECM Cell Adhesion
Array
Cells were seeded in a 96-well plate and treated with exendin-4
(0.3 mM) on the following day; after 24 or 48 h they were washed
and incubated with bengal rose stain (0.25% in PBS, pH 7.3), then
incubated for 30 minutes with an ethanol/PBS 1:1 solution,
allowing the adherent cells to release the stain, which was
evaluated by an optical plate reader (Victor 3, Perkin-Elmer) at
560 nm. The interaction of the NB and FNC cells with different
extracellular matrix (ECM) proteins was evaluated using an ECM
cell adhesion array (Chemicon Int., Millipore, Billerica, MA,
USA). Exendin-4 treated or untreated cells (106 cells/ml) were
non-enzymatically dissociated, resuspended in the assay buffer,
seeded in a 96 well and incubated at 37uC for 5 h, allowing them
to adhere to the protein-coated wells, and then washed. 100 ml of
the cell stain solution was added for 5 minutes and then removed.
The wells were washed and air-dried. Subsequently, the extraction
buffer was added for 10 minutes and the absorbance was
determined.
2D and 3D Matrigel Cultures
Matrigel (BD Bioscience, Bedford, MA) was thawed overnight
on ice, diluted with cold serum free media (1:3) and used both for
the thin and thick gel methods. For the former, 50 ml Matrigel/
cm2 of growth surface was used. The plates were allowed to sit for
30 minutes at 37uC and washed with serum free medium. Finally,
cells were plated on top of the gel, with or without exendin-4, to
evaluate cell morphology (2D cultures). For the latter, cells were
added to Matrigel and suspended using cooled pipettes. Cell/
Matrigel suspension (150 ml/cm2 of growth surface) was added
and the plates were placed for 30 minutes at 37uC. Finally, growth
medium was added to each well (3D cultures).
Real-time RT-PCR
Total RNA was extracted using Nucleospin RNA II (Macherey
Nagel) and reverse transcribed with TaqManH Reverse Tran-
scription Reagents (Applied Biosystems Inc., Foster City, CA).
Primers and probe for uPAR (Hs00182181_m1), CXCR4
(Hs02330069_s1), microtubule-associated protein-2 MAP2
(Hs00159041_m1), Tau (Hs00902193_m1), Synaptophisin
(Hs00300531_m1), Tissue inhibitor of metalloproteinases-1
(TIMP-1) (Hs99999139_m1), Matrix Metalloproteinase-9 (MMP-
9) (Hs00957562_m1) were Assay-On-Demand products (Applied
Biosystem). Primers and probe for human GLP-1R were R: 59-
GGCCAGCAGGCGTATTCA-39 F: 59-CCTCCTGCCACA-
GACTTGTTC-39 probe: 59 FAM-CAACCGGACCTT CG-
TAMRA 39. Each measurement was carried out in triplicate.
The mRNA quantization was based on the comparative Ct (for
cycle threshold) method and normalized to ribosomal 18S RNA
expression.
Electrophysiological Analysis
Patch pipettes (3–7 MV ) made as previously reported [17] were
used for whole-cell current- and voltage-clamp recordings and
filled with a solution containing (mM): 150 CsBr, 5 MgCl2, 10
EGTA and 10 HEPES. pH was 7.2, with KOH. Coverslips with
the adherent cells (FNC after 48 h, and SK-N-AS up to 48 h) in
culture, without (Control) and with exendin-4 were superfused as
described previously [17]. Tetrodoxin (TTX) (1 mM) was used to
test the voltage activated Na+ channels. To suppress K+ currents
we made experiments in a 20 mM-TEA bath solution [17]. A
Na+- and K+-free solution (Tetraethylammonium (TEA)-Ca2+
bath solution) was used to record Ca2+ currents [17]. To avoid the
occurrence of the high voltage activated (HVAC) L-type Ca2+
currents, nifedipine (10 mM) was used; Cd2+ (0.8 mM) was used to
block all the other HVACs. Ni2+ (50 mM) was used to block T-type
Ca2+ currents [22]. Stretch activated channel (SAC) sensitivity was
Figure 2. Cell adhesion assay. Effect of 24 h 0.3 mM exendin-4 treatment on cell adhesion as assessed by Bengal rose assay. Data are mean 6 SE
of three independent experiments. EXE = exendin-4. * = p,0.05 vs related control (FBS 2%); FBS 10% was the positive control.
doi:10.1371/journal.pone.0071716.g002
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Figure 3. Cell adhesion assay on different ECM proteins and uPAR expression. Representative experiment on the effect of 0.3 mM exendin-
4 on the adhesion of SH-SY5Y and SK-N-AS cells on different ECM proteins. * = p,0.05 vs. related control (A); Bengal rose adhesion assay performed
on SK-N-AS (B) and SH-SY5Y (C) cells plated on vitronectin and treated with 0.3 mM exendin-4 for 24 h. A representative experiment of three
independent experiments is shown in each case. * = p,0.05 vs. control; expression of uPAR as assessed by real-time RT-PCR in SK-N-AS and SH-SY5Y
cells treated with 0.3 mM exendin-4 for 24 h. Mean percentage 6 SE of four independent experiments. EXE = exendin-4. * = p,0.05 vs. control cells
(D).
doi:10.1371/journal.pone.0071716.g003
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evaluated as reported previously [23], [17]. INa currents were
recorded in cells bathed in 20 mM TEA solution with nifedipine
by applying a pulse protocol from a HP of 280 mV with 10– ms
step pulses ranging from –70 to 50 mV in 10-mV increments. ICa
currents were elicited in TEA–Ca2+ solution with TTX added
from a HP of 280 mV by 1-s depolarizing steps from 270 to
50 mV in 10-mV increments. The HP was held at 240 mV to
inactivate most of INa and ICa; a pulse protocol, 100 ms long,
ranging from 280 to 0 mV in 10-mV increments was applied
from a pre-step to 260 mV. The steady-state Na+ and Ca2+
currents activation was evaluated by
Ia(V )~Gmax(V{Vrev)= 1zf exp Va{Vð Þ=ka½ g ð1Þ
and the steady-state inactivation by
Ii(V )~I= 1zf exp{ Vi{Vð Þ=ki½ g ð2Þ
where Gmax is the maximal conductance for the Ia, Vrev is the
apparent reversal potential, Va and Vi are the potentials eliciting
the half-maximal current size, ka and ki are the steepness factors.
Passive membrane capacitance, Cm, and conductance, Gm, were
evaluated as reported previously [22]. The resting membrane
potentials (RMP) were recorded by switching to the current clamp
mode of the 200 B amplifier.
Migration Assay
NB cell migration was measured in chemotaxis Boyden
chambers. 13 mm PVP-free polycarbonate filters with 8 mm pores
were coated using a Collagen type I solution (50 mg/ml in HCl
2 mM), air-dried and washed twice in serum-free RPMI medium
with 0.2% bovine serum albumin (BSA). The lower compartment
of the Boyden chamber was filled with 10% FBS RPMI or serum-
free hMSC conditioned culture medium, the upper chamber
contained the cell suspension (30000 cells/chamber in serum-free
RPMI) treated or not with exendin-4. After incubation, the filters
were removed and fixed with cold methanol for 30–40 minutes,
then stained with the Diff-Quick kit (Dade Diagnostics of Puerto
Rico Inc., Aquada, Puerto Rico) following the manufacturer’s
instruction. The migrated cells were photographed with a phase-
contrast microscope (Axiovert 25 Zeiss, NY, USA) at 400X
magnification; 10 random fields were counted for each experi-
mental point.
Invasion Assay
The assay was performed in NB cells treated with exendin-4
(0.3 mM) by using the BD Matrigel Invasion Chamber kit (BD
Biosciences, Bedford, MA), following the manufacturer’s instruc-
tions. The culture medium (RPMI with 10% FBS) was added to
the wells of the plate as the chemotactic agent and immediately
after the cell suspension was added to the inserts. At the end of the
22 h incubation, the non-migrated cells were removed, the
Figure 4. Effects of exendin-4 on SK-N-AS and SH-SY5Y in 2D or 3D matrigel cultures. Representative 400X phase-contrast inverted
microscope fields of: SH-SY5Y control (A) and exendin-4-treated (B) cells after 1 h plating on top of matrigel; SK-N-AS control (C) and exendin-4-
treated (D) cells after 3 h plating on top of matrigel: the arrows show the adherent cells in contrast to detached, rounded and refractile cells.
Representative 100X phase-contrast inverted microscope fields of SH-SY5Y control (E) and exendin-4-treated (F) cells, SK-N-AS control (G) and
exendin-4-treated (H) cells, FNC control (I) and exendin-4-treated (L) cells after plating inside matrigel for 48 h; long thin neuritic protrusions are
indicated by the arrows and are suggestive of a more differentiated phenotype. EXE = exendin-4.
doi:10.1371/journal.pone.0071716.g004
Figure 5. Neuronal markers expression. Expression of the neuronal markers MAP2, Tau and SYP after plating cells inside matrigel for 48 h,
assessed by real-time RT-PCR. Results are expressed as mean fold increase 6 SE vs. related control, taken as 1, of three independent experiments.
* = p,0.05 vs. related control cells.
doi:10.1371/journal.pone.0071716.g005
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migrated cells were fixed with cold methanol and stained using a
Diff-Quick kit (Dade Diagnostics of Puerto Rico Inc) and then
photographed at 200X magnification using a phase-contrast
microscope AxioVision Zeiss (Zeiss Gottingen, Germany). The
migrated cells were quantified considering 10 random fields per
membrane.
Soft-agar Colony Formation Assay
After assessing cell viability, 26104 cells were seeded in the
presence of exendin-4 in triplicate in grid 60 mm dishes in 0.6%
agar with 0.8% agar underlay. After 7, 14 and 21 days the plates
were stained with 50 mg/ml MTT for 4 h at 37uC and the
diameter of the colonies was measured. Experiments were
repeated three times and for each experimental point, three plates
were used.
Figure 6. Analysis of passive properties and ionic current densities in FNC and SK-N-AS cells. Data were evaluated until 48 h in culture.
Effect of Exendin-4 (EXE) on RMP (A), on membrane capacitance, Cm (B), and resting specific membrane conductance Gm/Cm (C). * p,0.05 EXE-
treated cells vs. the related control; 1 and 11 p,0.05 and,0.01 SK-N-AS 48 h vs. 24 h; {,0.05 and {{,0.01 SK-N-AS+Exendin-4 48 h vs. 24 h. FNC at
48 h, SK-N-AS at 24 and 48 h data are from 26, 28 and 32 cells, respectively. Effect of EXE on ISAC/Cm (D), INa/Cm (E), ICa,T/Cm (F) and ICa,L/Cm (G). * and
** p,0.05 and P,0.01 EXE treated cells vs. the related control; 1, 11 and 111 p,0.05,,0.01 and,0.001 SK-N-AS 48 h vs. 24 h; {,0.05, {{,0.01 and
{{{ 0.001 SKNAS +EXE 48 h vs. 24 h. ISAC/Cm INa/Cm, ICa,T/Cm and ICa,L/Cm in FNC at 48 h, SK-N-AS at 24 and 48 h data in each experimental condition
are from 14–18 cells.
doi:10.1371/journal.pone.0071716.g006
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Statistical Analysis
Results are expressed as mean 6 standard error (SE).
Significance of differences (p values ,0.05) between means was
tested by one-way ANOVA with repeated measures followed by
the appropriate post-hoc test.
Results
Effect of Exendin-4 on Cell Adhesion
The presence of the GLP-1R in cells was evaluated by RT-PCR
analysis (Fig. 1A). To test the effect of exendin-4 on cell
proliferation and survival, we treated the cells with the GLP-1
receptor agonist exendin-4 at the dose of 0.3 mM. Exendin-4 did
not significantly alter DNA synthesis (Fig. 1B), cell viability or cell
counts (not shown). To demonstrate a possible effect of exendin-4
on cell adhesion, we performed a Bengal rose assay and we
observed an increased number of adherent cells at 48 h in all the
cells models (Fig. 2). In order to characterize which components of
the Cell Adhesion Molecules (CAM) were involved in the
increased adhesion properties, we screened the ability of the cells
to adhere to different ECM proteins: collagen I, collagen II,
collagen IV, fibronectin, laminin, tenascin, vitronectin. We found
that both SH-SY5Y and SK-N-AS cells treated with exendin-4
augmented their interaction with vitronectin (Fig. 3A). Conversely,
exendin-4 did not affect the adhesion of FNC to the proteins tested
(Fig. S1A). To confirm data obtained with arrays, we performed
cell adhesion tests in plates coated with vitronectin, and we found a
significantly increased number of adherent NB cells (Fig. 3B and
C), but not FNC cells (Fig. S1B). Moreover, since vitronectin is a
major urokinase plasminogen activator surface receptor (uPAR)
ligand with a role in cell adhesion, we measured the receptor
expression by real-time RT-PCR, in order to evaluate whether
exendin-4 increases the adhesion to vitronectin by up-regulating
uPAR. As shown in figure 3D, exendin-4 did not increase uPAR
expression in the two NB cell lines and actually mRNA levels
appeared decreased (significantly in SK-N-AS), thus confirming
that uPAR does not play a role in the stimulatory effect of exendin-
4 on cell adhesion.
Effects of Exendin-4 in 2D and 3D Culture Models
In vitro 3D cultures are relevant models of the cell-cell and cell-
stroma interactions in both normal and cancer tissues [24] and
allow the study of cellular differentiation, organization and
migration. Using matrigel, we set up 2D cultures, plating cells
on top, and 3D cultures, suspending cells inside the matrigel. We
observed that soon after plating cells on top of matrigel, the
number of cells spreading on the matrix was higher in samples
exposed to exendin-4 than in controls (6268% vs. 3667% for SH-
SY5Y after 1 hour p,0.05; 5566% vs. 2865% for SK-N-AS after
3 hours, p,0.05) (Fig. 4 A–D). No modification in adhesive
properties was detected in FNC cells cultured on top of matrigel
(Fig. S2). Furthermore, exendin-4-treated SH-SY5Y, SK-N-AS
and FNC cells suspended inside the matrigel showed a rapid
adaptation to the 3D environment, resulting in a more evident
presence of neurite-like protrusions vs. control cells (Fig. 4 E–L). A
similar effect had been already reported on plastic support for
Table 1. Boltzmann parameters of activation and inactivation curves for INa and T- and L-type Ca
2+ currents.
Ip/Ip,cont G/Gcon Va (mV) ka (mV) Vi (mV) ki (mV)
INa
FNC (48 h) 1.060.1 160.1 230.162 8.060.6 265.165 7.560.7
FNC+EXE (48 h) 1.2760.1 ** 1.260.1 * 235.463 * 9.060.8 * 268.266 6.860.6
SKNAS (24 h) 1.060.1 1.060.1 22562 860.7 268.166 6.960.5
SKNAS+EXE (24 h) 1.2660.1 ** 1.260.1 ** 23063 * 7.860.6 271.867 6.960.6
SKNAS (48 h) 1.060.1 1.060.1 232.363 7.860.6 264.266 7.460.7
SKNAS+EXE (48 h) 1.2460.1 ** 1.3360.1 * 237.163 * 8.560.7 * 26.966 6.660.6 *
ICa,T
FNC (48 h) 1.060.1 1.060.1 234.562 5.760.4 264.865 4.560.2
FNC+EXE (48 h) 1.660.2 ** 1.160.1 * 237.663 * 5.560.3 270.466 * 4.260.3
SKNAS (24 h) 1.060.1 1.060.1 22562 460.2 260.066 4.960.2
SKNAS+EXE (24 h) 1.260.1 * 1.260.1 * 23063 * 460.2 267.166 * 4.960.3
SKNAS (48 h) 1.060.1 1.060.1 23463 5.660.5 265.766 4.660.3
SKNAS+EXE (48 h) 1.360.1 * 1.260.1 * 241.064 * 5.460.6 272.266 * 4.060.3 *
ICa,L
FNC (48 h) 1.060.1 1.060.1 1762 7.460.6 250.065 7.560.6
FNC+EXE (48 h) 1.660.2 ** 1.260.1 * 22262 ** 7.060.2 255.265 * 6.960.6
SKNAS (24 h) 1.060.1 1.060.1 21661 7.460.8 245.164 6.960.5
SKNAS+EXE (24 h) 1.460.2 ** 1.260.1 * 22062 ** 7.460.5 247.764 6.960.6
SKNAS (48 h) 1.060.1 1.060.1 218.762 7.560.6 247.665 ** 7.560.7
SKNAS+EXE (48 h) 1.860.2 *** 1.360.1* 225.062 *** 6.460.6 * 256.665 ** 6.560.5 *
Effect of exendin-4 treatment on Boltzmann parameters of activation and inactivation curves for INa and T- and L-type Ca
2+ current in FNC and SK-N-AS cells. * = p,0.05,
** = p,0.01 and *** = p,0.001 vs. the related control. Ip/Ip, cont and G/Gcont, represent the ratio of the peak currents and conductance in exendin-4 treated cells respect
to their corresponding control. Va and Vi are the half-voltages of activation and inactivation, respectively. ka and ki are the steepness factors for the activation and
inactivation Boltzmann curve. EXE = exendin-4.
doi:10.1371/journal.pone.0071716.t001
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exendin-4-treated SH-SY5Y [17], whereas no effect was observed
in SK-N-AS or FNC cells (not shown). We measured the
expression of the neuronal markers MAP2, Tau and Synaptophy-
sin; a significant increase of the transcripts in the cell lines tested
was found, with the only exception of Tau in FNC (Fig. 5).
Effects of Exendin-4 on the Membrane Passive Properties
When recorded in physiological bath solution the resting
membrane potential (RMP) was similar in both control and
exendin-4 treated cell models at 48 h, whereas exendin-4-treated
SK-N-AS cells appeared more depolarized at 24 h (Fig. 6A). The
cell-surface area evaluated by the membrane capacitance (Cm) was
significantly higher (Fig. 6B), whereas the specific resting
membrane conductance (Gm/Cm) was reduced in both exendin-
4-treated SK-N-AS and FNC (Fig. 6C). Such a reduction of Gm/
Cm is in agreement with diminished membrane leak currents and
is an index of cell differentiation induced by exendin-4.
Accordingly, the Gm/Cm values in SK-N-AS at 24 h were greater
than those recorded at 48 h in both control and exendin-4-treated
cells. The results obtained in SK-N-AS at 48 h were similar to
those observed in SH- SY5Y at the same time, as previously
reported [17].
Effects of Exendin-4 on the Current Density of Stretch-
activated Channel in FNC and SK-N-AS Cells
Actin polymerization and its contractile status increase plasma
membrane stiffness [25] and in turn increase the ISAC/Cm [23].
Moreover, we have demonstrated that exendin-4 treatment in SH-
SY5Y cells dramatically increased F-actin accumulation and
potentiated ISAC/Cm [17]. Here, we evaluated the action of
exendin-4 on this latter parameter in the other neuronal cell
model, i.e. SK-N-AS, and in FNC. The results clearly indicate that
exendin-4 dramatically increased ISAC/Cm in both FNC and SK-
N-AS. Interestingly, untreated SK-N-AS cells at 24 h showed a
greater ISAC/Cm than at 48 h (Fig. 6D), and reduced size of INa/
Cm (Fig. 6E) and ICa,L/Cm (Fig. 6G) whereas were less potentiated
by exendin-4 treatment (Fig. 6D). Again, these findings confirm
the more differentiated state at 48 h than at 24 h.
Effects of Exendin-4 on Voltage-dependent Ionic
Channels in FNC and SK-N-AS Cells
In 20-mM TEA solution, untreated cells at 48 h exhibited INa,
as shown in a typical experiment performed with FNC (Fig. 7A).
The voltage threshold of INa was about 260 mV. The maximal
INa was observed at 215 mV and was greater in SK-N-AS than
in FNC. The treatment with exendin-4 increased INa amplitude
(1.2 and 1.2 fold in SK-N-AS and FNC) (Fig. 7A, B and 6E). The
normalized I–V plot is shown in Fig. 7C. The maximal current
amplitude was elicited at 21565 mV in control SK-N-AS and
FNC cells, but it was shifted at 22065 mV in exendin-4 -treated
cells (Fig. 7C). Exendin-4 treatment changed the activation and
inactivation data (Fig. 7D). In particular, the maximal current to
peak (INa/Cm) and Gmax/Cm values increased to a similar
extent than control, suggesting that the rise in current density was
related to the channel conductance increase. The half voltage
activation and inactivation values, Va and Vi, obtained by the
Boltzmann fit, were shifted towards more negative potentials, of
about 5 and 3 mV (SK-N-AS) and 7 and 4 mV (FNC),
respectively. In contrast, ka values were unchanged, whereas ki
diminished (Fig. 7D; Table 1). Therefore, we suggest that exendin-
4 improved the INa occurrence both by significantly shifting Va
and Vi and by enhancing Na+ channels conductance. The
expression of functional Ca2+ channels was assessed in TEA-Ca2+
bath solution (Fig. 7E–O). In both cell types Ca2+ currents showed
a low-voltage-activated and inward transient current (T-type Ca2+
current, ICa,T) with a voltage threshold at 250 mV, and a high-
voltage-activated current with a slow inactivation (IHVA), which
became evident from 240 mV. The fitting procedure to the
activation and inactivation curves of these two currents resulted in
two Boltzmann terms that were in agreement with T- and HVAC
currents (Fig. 7 N–O). To verify this suggestion we added the L-
type Ca2+ blockers Cd2+ or nifedipine to the bath. In our records
T-type current was not affected by both molecules (Fig. 7H–I),
whereas HVAC was blocked by Cd2+ and only partly by
nifedipine. In fact, the current traces still showed a HVAC having
amplitude of about the 10% of the control. Consequently, we can
reasonably suppose that HVAC currents consisted of a large
nifedipine-sensitive L- type current with a small fraction of other
HVAC Ca2+ currents superimposed, most likely N, P, Q or R-
types (Fig. 7G). Exendin-4 significantly increased ICa,T, and ICa,L,
amplitude (Fig. 6 F–G). The normalized I–V plots and the related
normalized Boltzmann curve related to T- and L-type current are
shown in figure 7 L–M. Again, changes similar to those observed
for INa were induced by exendin-4 in Ca
2+ currents, such as an
increase in Gmax,Ca,T/Cm and Gmax,Ca,L/Cm, a shift towards a
more negative potential of Va and Vi and a decrease of ka and ki.
Figure 7. Analysis of voltage-dependent Na+ and Ca2+ channels in FNC and SK-N-AS cells. Typical INa traces recorded in a SK-N-AS cell. The
voltage threshold of INa was at 250 mV (A). Effect of Exendin-4 (EXE) on INa amplitude (B). In A, B numbers represent the voltages eliciting the
maximal INa. C) Normalized I–V plots represent the data evaluated at the current peak in all the cells investigated; the Boltzmann fits (Eq. 1) are
superimposed to the experimental data. D) Normalized data related to INa activation and inactivation and superimposed Boltzmann fit in control SK-
N-AS and under exendin-4 treatment; the Boltzmann curves for activation are determined from panel C by the equation:
m~1z exp Va{Vð Þ=ka½ ~Gmax(V{Vrev)=Ia(V ) and inactivation from eq. 2; Boltzmann parameters listed in Table 1. Data represent mean 6 SE
from 26–43 cells. Representative ICa,tot traces obtained in a control (E) and in exendin-4 treated FNC cell (F). The arrow in the 250 mV trace indicates
the presence of a first component as a fast-activating current, ICa,T. High-voltage-activated and slowly inactivating current (ICa,L, HVA) as a second
component starting from240 mV. Ca2+ currents elicited by a voltage step at220 mV without (Cont) and in the presence of nifedipine (Nif), Cd2+ and
Ni2+(G). Representative ICa,T recorded at a holding potential of –50 mV without (H), and with exendin-4 (I). Normalized I–V plots determined at the
current peaks in control and under exendin-4 treatment related to ICa,T (L) and ICa,L (M). Normalized activation and inactivation data for T- (N) and L-
type Ca2+ current (O) in control and under exendin-4 treatment, with the related Boltzmann fit superimposed to the data. The related Boltzmann
parameters are listed in Table 1. In each experimental condition, data are from 18 to 23 cells.
doi:10.1371/journal.pone.0071716.g007
Table 2. Mean percentage 6 SE of migrated cells in response
to SDF-1, IGF-1 or PDGF in the presence of exendin-4,
compared to untreated cells, taken as 100%.
+SDF-1 +IGF-1 +PDGF
SH-SY5Y 5564%* 7163%* 6262%*
SK-N-AS 5861%* 6862%* 5364%*
* =p,0.05 vs. the related control.
doi:10.1371/journal.pone.0071716.t002
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Figure 8. Migration assay. Effect of 0.3 mM exendin-4 (EXE) on FBS-induced migration of cells as assessed by Boyden chambers migration assay.
Results are reported as mean percentage of migrated cells/field6 SE of four independent experiments, considering at least 10 random fields for each
experimental point. * = p,0.05 vs. control (A); representative phase contrast inverted microscope pictures of migrated SH-SY5Y control (B) or
exendin-4-treated (C) cells (50X magnification); SK-N-AS control (D) or exendin-4-treated (E) cells; FNC control (F) or exendin-4-treated (G) cells (400X
magnification).
doi:10.1371/journal.pone.0071716.g008
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Notably, both the increase of the maximal current amplitude and
the conductance of T- and L-type Ca2+ currents were greater than
those of INa, and the highest increases were those related to L-type
Ca2+ current (Table 1). Again, the results obtained in SK-N-AS at
48 h were similar to those observed in SH-SY5Y at the same time
as previously reported [17].
Figure 9. Cell migration in response to different stimuli and CXCR4 expression. Representative experiment showing the effect of exendin-4
on the migration of NB cells and FNC cells. NB cells were induced to migration also by hMSC-conditioned culture medium (CM) (A). Expression of
CXCR4 detected by real-time RT PCR and reported as fold-increase vs. related control. EXE = Exendin-4 (B). * = p,0.05 vs. related control.
doi:10.1371/journal.pone.0071716.g009
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Figure 10. Invasion ability evaluation on exendin-4 treated cells. Representative experiment from three independent experiments on the
invasive ability of SK-N-AS and SH-SY5Y cells after treatment with 0.3 mM exendin-4 (A); real-time RT-PCR analysis of the expression of MMP-9 and
TIMP-1 in NB cells after treatment with 0.3 mM exendin-4 for 6 h. * = p,0.05 vs. related control (B). Size of the cell colonies grown in soft agar 7, 14 or
21 days after suspension, with or without (C = control) exendin-4. Data are reported as mean percentage vs. related control of three replicates.
EXE = exendin-4; * = p,0.05 vs. related control; #=p,0.05 vs. C 7d; 1=p,0.05 vs. C 14d (C).
doi:10.1371/journal.pone.0071716.g010
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Effect of Exendin-4 on Cell Migration
Treatment with exendin-4 significantly reduced the migration of
SH-SY5Y, SK-N-AS and FNC cells, as assessed by Boyden
chambers. Figure 8A shows the counts of the migrated cells in
three different experiments. Representative photographs of the
filters are shown in figure 8 B-G. NB has as a preferential site of
metastasization in the bone marrow. To test the influence of
exendin-4 on the migration of SH-SY5Y and SK-N-AS towards
the bone, we performed migration assays using a culture medium
conditioned by hMSC, obtained from bone marrow of healthy
donors and isolated as previously reported [19]. These cells secrete
in vitro SDF-1, the major chemokine involved in the metastasiza-
tion of NB to the bone marrow [26]. We determined the release of
SDF-1 by hMSC in the culture medium by ELISA and we
detected a concentration of 28.2 pg/ml. As expected, NB cells
were strongly induced to migrate towards the conditioned
medium, as well as towards the potent chemoactractant FBS.
Exendin-4 significantly inhibited this process both in SK-N-AS
and in SH-SY5Y (Fig. 9A). Moreover, migration assays were
performed using SDF-1 (100 ng/ml) and different molecules
known for their chemoactractant properties on several tumor cells
including NB cells [e.g. Insulin like Growth Factor-1 (IGF-1) [27]
and Platelet-Derived Growth Factor (PDGF) [28]]. Exendin-4
significantly reduced cell migration in all the conditions tested
(Table 2). We also determined the influence of exendin-4 on the
expression of the chemokine receptor for SDF-1 CXCR-4; the
expression of CXCR4 was not affected by exendin-4 in NB cells
whereas in SK-N-AS cells SDF-1 induced an increase of CXCR4
mRNA (Fig. 9B). Collectively, these results indicate that exendin-4
is able to reduce cell migration independently of the type of the
chemoattractant used.
Exendin-4 Affects Tumor Phenotype
The invasive potential of cells in the presence of exendin-4 was
evaluated using a modified Matrigel Boyden chamber assay.
Exendin-4 significantly decreased cell invasion in SK-N-AS. In
agreement with this finding, a marked increase in the expression
level of TIMP-1 was observed (Fig. 10 A–B). On the contrary,
exendin-4 increased cell invasion in SH-SY5Y cells and this effect
was paralleled by a significant increase of both MMP-9 and
TIMP-1 expression levels (Fig. 10 A–B). However SH-SY5Y, in
contrast to SK-N-AS, are also able to grow in soft agar and this
anchorage-independent growth is correlated with in vivo oncogenic
potential. We performed a long term exendin-4 treatment (7–21
days) of SH-SY5Y cells in soft agar assay and we observed a
significant inhibition of the size of the colonies (Fig. 10C).
Altogether, these findings suggest that exendin-4 promotes the
acquisition of a more differentiated phenotype in SH-SY5Y cells.
Discussion
In this work we described the effects of the long-acting GLP-1R
agonist exendin-4 on adhesion, differentiation and migration of
NB cells. We previously observed a substantial remodelling of
actin and tubulin at the cytoskeletal level following treatment with
exendin-4 in SH-SY5Y cells [17]. Such evident changes and the
formation of actinic stress fibres may also occur in conditions of
altered adhesion and migration abilities [29]. Thus, we hypoth-
esized that the observed changes in the structure of the
cytoskeleton could also be linked to altered cell adhesion and/or
cell migration properties, fundamental for tumor spread and
metastasization. We conducted both cell adhesion and migration
experiments in the NB cell lines SH-SY5Y and SK-N-AS and in
FNC, used as a neuronal control model. Exendin-4 was able to
significantly increase cell adhesion and reduce cell migration. The
characterization of the molecules involved in cell adhesion showed
that in the NB models, but not in FNC, exendin-4 caused an
alteration in the expression of adhesive molecules and markedly
increased adhesion to vitronectin. In agreement with this finding,
increased adhesion to vitronectin has been observed in NB cells
differentiating into neurons or gangliocytic cells in vivo and has
been found to promote neurite outgrowth of retinoic acid (RA)-
differentiated NB cells in vitro [30]. Adhesion to vitronectin
classically occurs through the involvement of alpha v-beta5
integrins, but also uPAR can bind vitronectin and its expression
levels have been correlated to higher aggressiveness of NB [31].
Nonetheless, exendin-4-treated cells did not display altered
expression levels of uPAR. The increase in the pro-adhesive effect
of exendin-4 was also evident in 2D matrigel cultures, where the
phenomenon occurs earlier. In fact, exendin-4 treated NB cell
lines grown on top of matrigel showed a higher degree of
spreading compared to control already after 3 h. Furthermore, in
experiments of cell migration we observed a significant reduction
of the cell motility independently of the chemoattractant stimulus
(FBS, hMSC conditioned medium, SDF-1). A previous study
clarified that many NB cell lines express both SDF-1 and its
receptor CXCR4 and their expression is probably regulated
through an autocrine circuit. The cells are able to migrate in
response to an SDF-1 gradient produced into the bone marrow,
one of the main metastasization sites for NB, through a tight
regulation of the expression of CXCR4 [32]. We did not observe
alteration of the expression of the receptor after exendin-4
treatment in NB cells. Moreover, exendin-4 can effectively reduce
cell migration when stimulated through other receptors such as
IGF-1-R e PDGF-R. These data support the hypothesis that the
effects of exendin-4 occur downstream the receptor stimulation
probably acting at the cytoskeletal level. This effect, which we
describe for the first time in NB cells, has been reported in human
CD4+ lymphocytes [33]. The authors showed that GLP1-R
stimulation inhibited cell migration independently of the chemo-
tactic stimulus used. Accordingly, our results indicate that in NB
cells exendin-4 inhibits the migration induced by both IGF-1 and
PDGF. Moreover, Marx et al. [33] showed that the observed
effects are not due to alterations of the expression of chemokine
receptors, nor to altered cell viability. Similarly, our data on
CXCR4 expression, cell viability and proliferation showed no
significant alteration after treatment with exendin-4, whereas
reduction of cell viability and enhanced apoptosis have been
reported for other tumors such as breast [9] and colon [8] cancer
cells. We had previously demonstrated that exendin-4 induced a
more differentiated phenotype in SH-SY5Y cells [17]. Here we
reported a similar effect also in SK-N-AS and FNC cells.
Noteworthy, these effects of exendin-4 on cell morphology and
on the expression of the neuronal markers MAP2, Tau and
synaptophysin are evident only when the cells are cultured in a
tridimensional environment. These results strongly support the
notion that mechanical cues from the ECM might also influence
the induction of differentiation, thus regulating clinically-relevant
aspects of NB biology [34]. On the other hand, the specific
neuronal electrophysiological properties are detectable also when
the cells are treated with exendin-4 on a plastic plate. The analysis
of the membrane passive properties showed a significant Gm/Cm
decrease, in agreement with a reduced membrane aspecific
current and suggesting more specific control of resting permeabil-
ity; therefore, it may be considered as an indicator of cell
differentiation induced by exendin-4. Our results also indicate that
exendin-4 dramatically increased ISAC/Cm in all the cell models
compared to controls. This major activation of SACs may be a
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consequence of an increase of plasma membrane stiffness [25],
[23] due to an increased F-actin polymerization and its contractile
status [17]. Again, these findings confirm the more differentiated
state induced by exendin-4. A detailed analysis of the major
neuronal ionic currents evoked on the three different cell types
once more confirms a striking differentiating effect of exendin-4.
In any case, the increase in Na+ and Ca2+ current density indicates
an improved achievement of the features that are typical of
excitable cells. The increased INa availability may be accomplished
by increasing the expression and/or conductance of the Na+
channels. Similarly, we observed changes induced by exendin-4 in
Ca2+ currents, such as an increase in Gmax,Ca,T/Cm and
Gmax,Ca,L/Cm, a shift towards a more negative potential of the
half-maximal voltage of activation and inactivation, Va and Vi and
a decrease of ka and ki. Notably, both the increase of the maximal
current amplitude and the conductance of T- and L-type Ca2+
currents were greater than those of INa, and the highest increases
were those related to L-type Ca2+ current, which was the prevalent
HVAC current observed in our cell models.
Moreover, in SK-N-AS cells exendin-4 reduced the ability to
migrate through proteolytic degradation of the ECM, as assessed
by invasion assays, and this effect was associated with an increased
expression of TIMP-1. On the contrary, in SH-SY5Y the
increased number of invading cells was paralleled by an up-
regulation of both MMP-9 and TIMP-1. These apparently
surprising data can be interpreted as a differentiation process
rather than the acquisition of a more aggressive phenotype; in fact
the transient increase of MMPs expression in RA-treated SH-
SY5Y [35], [36] probably allows the ECM degradation by
growing cell neurites [37]. Indeed, we evaluated the long term
effects of exendin-4 on soft agar colony formation, to test the
modulation of cell metastatic potential [38]. Different NB cell lines
display heterogeneity in malignant potential because they resemble
the characteristics of the tumor from which they originate [39].
SH-SY5Y cells, but not SK-N-AS, can grow and form colonies
when suspended in soft agar. In these experimental conditions,
exendin-4-treated SH-SY5Y showed a significant reduction of the
size of colonies, indicating that exendin-4 restores the anchorage
dependence of cells. This effect is again in agreement with the
acquisition of a less aggressive phenotype.
In conclusion, in this study we provided for the first time
evidence that exendin-4 effectively promotes cell adhesion, induces
differentiation and inhibits cell migration in NB cells. Thus, this
study provides further evidence that exendin-4 has pleiotropic
effects that extend beyond its hypoglycaemic activity and possibly
include anti-tumoral effects. With regard to this issue, in NB RA
has become a routine treatment option [40]. However, NB cells
show heterogeneity in retinoid signalling [37], thus originating
different sensitivity to this therapeutic approach. Admittedly, in
order to verify whether exendin-4 might be considered an
alternative treatment strategy in selected patients, additional
studies, including for instance in vivo studies in xenograft models,
are needed. This is undoubtedly an important step, if we consider
that different responses may be observed in different experimental
conditions, tissues or species. For example, GLP-1R agonists have
been associated to increased cAMP production and thyroid C-cell
proliferation and tumor formation in rodents but not in primates,
including humans [41], [42]. Pancreatitis and pancreatic cancer
have been more commonly reported in patients treated with GLP-
1 agonists (i.e. sitagliptin and exenatide), but the same has been not
observed for all other cancers [43]. However, a recent meta-
analysis of serious adverse events reported with exenatide or
liraglutide treatment was reassuring and did not support an
increased risk of pancreatitis or any cancer development [44].
Supporting Information
Figure S1 A Cell adhesion assay on different ECM
proteins. Representative experiment on the effect of 0.3 mM
exendin-4 on the adhesion of FNC cells on different ECM proteins
vs control (i.e. not-treated) cells. B. Bengal rose adhesion
assay. Representative experiment performed on FNC cells plated
on vitronectin and treated with 0.3 mM exendin-4 for 24 h.
Control = not-treated cells.
(TIF)
Figure S2 Effects of exendin-4 on FNC in 2D matrigel
cultures. Representative 400X phase-contrast inverted micro-
scope field of FNC control (A) and exendin-4 treated (B) cells after
3 h plating on top of matrigel.
(TIF)
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